About Apollo, Inc.
Apollo Endosurgery, Inc. is revolutionizing the treatment of obesity and other gastrointestinal disorders by developing less invasive solutions for a whole new group of patients not seeking treatment today. Apollo is a global innovator pushing boundaries to bring new technologies and innovative products to markets in over 80 countries today. In particular, Apollo’s bariatric products fill the gap between non-surgical weight loss solutions and invasive surgeries, allowing physicians to do more for those patients who require more than drug therapy and dietary advice.
Apollo Endosurgery, Inc. was founded upon the initial work of the Apollo Group, an international think tank of world-renowned gastroenterologists and surgeons from five leading universities (Mayo Clinic, Johns Hopkins, Medical University of South Carolina, University of Texas Medical Branch-Galveston and Chinese University-Hong Kong.) Disappointed with the pace of innovation in therapeutic flexible endoscopy, the Group assembled with the goal of advancing the use of long, flexible instruments deployed through a natural orifice in order to treat gastrointestinal disorders, including obesity, chronic reflux, and gastrointestinal cancers rather than simply diagnose. The partnership between clinical experts and Apollo’s experienced corporate team is an engine for innovative new products and commercial development of GI and minimally invasive surgical products and procedures.
Apollo is committed to the advancement of less invasive therapies and with sales and distribution on a global scale, Apollo, Inc. is helping to foster in a new era of less invasive therapies worldwide.
For more information regarding Apollo Endosurgery, go to: www.apolloendo.com.